Earn CME for related activities: www.naccme.com/oln
Filmed on location in New York during the Great Debates & Updates in Hematologic Malignancies 2015, this webcast is part of a series that focuses on controversial areas in the management of hematologic malignancies as nationally-recognized thought leaders take opposing sides on topics of clinical interest.
In this presentation, Dr. Peter Martin argues that a 48-year-old woman diagnosed with mildly symptomatic, low tumor burden, stage IV follicular lymphoma, who has a low risk FLIPI score and desires treatment should be treated with either R-CHOP or B-R.
© 2015 Imedex, LLC.
14 май 2015
